Stay updated with breaking news from Shenzhen kangtai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FILE PHOTO Metro Manila (CNN Philippines, May 16) The country received three new COVID-19 vaccine clinical trial applications, Science and Technology Undersecretary Rowena Guevara said Tuesday. The vaccine developers that applied to conduct Phase 3 trials were the West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd., Guevara said in a briefing. The undersecretary said evaluation of the applications submitted by the West China Hospital and Sichuan University, as well as Shenzhen Kangtai is underway while Eubiologics is still “completing some requirements.” Meanwhile, the Department of Science Technology is also waiting the World Health Organization s release of its final protocol and list of COVID-19 shots for its Solidarity vaccine trials in the country. Guevara said WHO is expected to submit the documents “by the end of the month.” ....
В Китае одобрена еще одна вакцина от COVID-19 для экстренного использования trud.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from trud.ru Daily Mail and Mail on Sunday newspapers.
Путин приветствовал участников фестиваля «Российская студенческая весна» regnum.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from regnum.ru Daily Mail and Mail on Sunday newspapers.
La Chine approuve l'utilisation d'urgence d'un autre vaccin contre le Covid-19 azertag.az - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from azertag.az Daily Mail and Mail on Sunday newspapers.
Senator Jaziri Alkaf Abdillah Suffian (left) and Boo during Yong Tai’s virtual signing ceremony. PETALING JAYA: Yong Tai Bhd has formalised its collaboration with China’s Shenzhen Kangtai Biological Products Co Ltd by entering into a definitive agreement for the Phase III clinical trials and commercialisation of the latter’s Covid-19 vaccine. This cements the collaboration that was set up with the head of agreement framework signed in December 2020. Yong Tai CEO Datuk Boo Kuang Loon said the agreement marks another milestone for the group in its foray into the pharmaceutical business and he is confident that the collaboration will bear fruit in the near term based on Shenzhen Kangtai’s track record. ....